Unicycive Therapeutics Price Target Raised to $29.56
A 12-month price target for Unicycive Therapeutics, Inc. stock was raised to $29.56, implying potential upside of 599%.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
A 12-month price target for Unicycive Therapeutics, Inc. stock was raised to $29.56, implying potential upside of 599%.